Abstract

Diabetes mellitus presents a significant global health challenge, with rising prevalence rates and diverse clinical manifestations. Precision medicine offers a paradigm shift in diabetes management by tailoring treatments to individual patient characteristics, including genetic predisposition, metabolic profiles, and lifestyle factors. This systematic review evaluates the current state of precision medicine approaches in diabetes management, highlighting advancements in risk stratification, pharmacogenomics, and personalized interventions. By synthesizing evidence from clinical trials, genetic studies, and emerging technologies, this review aims to elucidate the potential of precision medicine in optimizing diabetes care and improving patient outcomes.